Eli Lilly



Ebit Alterar Data
AbbVie USD 5.24B 1.5B 2024-12
Abbott USD 2.18B 486M 2025-03
ALKERMES USD 162.69M 46.46M 2024-12
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.8B 604M 2025-03
Baxter International USD 419M 28M 2024-12
Biogen USD 644.1M 100.9M 2024-12
Bristol-Myers Squibb USD 4.18B 30M 2025-03
Drreddys Laboratories INR 18.02B 1.22B 2024-12
Eli Lilly USD 3.7B 1.93B 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Indivior 71M 30M 2025-03
J&J USD 7.39B 2.04B 2025-03
Medtronic USD 2.17B 128M 2025-01
Merck USD 5.22B 339M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Novartis USD 4.86B 286M 2024-12
Novo Nordisk 33.82B 7.89B 2024-09
Perrigo USD 193.9M 11.5M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Prestige Brands USD 91.96M 7.62M 2024-12
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Sanofi EUR 2.22B 2.84B 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Zoetis USD 988M 30M 2024-12



Eli Lilly - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.